Companies Dominating the Anesthesia Drugs Market
- Hikma Pharmaceuticals Plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- GE Healthcare
- Aspen Pharmacare Holdings Limited
- Avet Pharmaceuticals, Inc.
- Par Pharmaceuticals
- Teva Pharmaceuticals
- Novartis AG
- Heron Pharmaceutical, Inc.
- Piramal Enterprises Limited
Browse Key Market Insights with Data Illustration:
In the News
- GE Healthcare was granted the FDA pre-market clearance (PMA) to, a multinational healthcare and medical technology business with headquarters in the United States, for its End-tidal (Et) control software, which is used to provide general anesthesia on the Aisys CS2 Anesthesia Delivery System. In addition to the benefits low-flow anesthesia provides for hospitals and the environment, the device has direct control over the end-tidal concentration, which reflects the medication level in the patient's blood.
- Hikma Pharmaceuticals PLC introduced midazolam injectable pouches containing 0.9% sodium chloride (NaCl) in dosages of 50 mg/50 mL and 100 mg/100 mL. In the US, the medication is authorized for continuous intravenous infusion for sedating adults, children, and newborns who are ventilated and oxygen-deprived during anesthesia or therapy in a critical care setting.
